28
Oct
2025

ST PHARM

Exhibitor at CPHI Frankfurt 2025 stand 5.0D16, Contract Manufacturing and Services
About Us

ST Pharm has been offering excellent custom manufacturing services of oligonucleotides and small molecule APIs CDMO to meet clients’ high expectation for their use in pharmaceutical development in compliance to cGMP requirements. The expansion of oligonucleotide production capabilities became a new growth engine for the future pharmaceutical industry. Based on the in-depth knowledge from manufacturing nucleoside to oligonucleotide, it has enabled ST Pharm to leverage its know-how into manufacturing polynucleotide, the mRNA. STLNP®, 5' capping reagent (SmartCap®), Phosphoramidite

  • KR
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Intermediates Manufacturer
Contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 5.0D16, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025